Le Lézard
Classified in: Health
Subject: SVY

United Kingdom Genetic Testing Market Outlook to 2024


NEW YORK, Nov. 20, 2017 /PRNewswire/ -- Summary

Read the full report: https://www.reportlinker.com/p03449096

GlobalData's new report, United Kingdom Genetic Testing Market Outlook to 2024, provides key market data on the United Kingdom Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
- Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United Kingdom Genetic Testing market.
- Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Read the full report: https://www.reportlinker.com/p03449096

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 08:35
Vistagen , a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced positive results from a Phase 2A pilot study of PH15, an...

at 08:34
Canopy Life Sciences ("Canopy"), a leading provider of clinical to commercial solutions to the life sciences industry, is delighted to announce the appointment of Susanne Clark as President. With over 25 years of experience in the life sciences...

at 08:34
Innovative Medical Products, Inc. (IMP) and Curexo Inc. are pleased to announce a global strategic distribution partnership combining Curexo's artificial joint surgical robot, CUVIS-joint, with IMP's industry-leading De Mayo D2® Knee Positioner....

at 08:32
As we celebrate World Malaria Day 2024, Malaria No More commends the incredible progress made by the U.S. President's Malaria Initiative (PMI), as outlined in its newly released 18th Annual Report to Congress....

at 08:32
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") , the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce their Lucyd smart frames are now available from NewLook.ca and...

at 08:31
Heart-Valve-Surgery.com, a leading patient advocacy group for heart valve disease, with support from Medtronic, a global leader in healthcare technology, today launched the "Aortic Stenosis Patient Activation Platform", an end-to-end digital platform...



News published on and distributed by: